Related posts

Oil and stocks climb on earnings week3 Best U.S. Healthcare ETFsOur 3 defensive healthcare stocks picks
Investor Insights

This summary was created by AI, based on 4 opinions in the last 12 months.

Becton Dickinson (BDX-N) is a healthcare supplier with a strong presence in North America and global exposure. The company has a good dividend, is held by institutions, and has steady earnings. With 90% of its products being disposable, Becton Dickinson has a steady stream of recurring revenue. The company is expected to see double-digit earnings growth and has a strong M&A strategy. Overall, experts believe that Becton Dickinson offers a good investment opportunity due to its cheap valuation and promising future.

Consensus
Positive
Valuation
Undervalued
BUY ON WEAKNESS
Becton Dickinson

Share have been flattened, but it's now cheap. They tell a good story.

Healthcare
BUY
Becton Dickinson

They have incredible reach with 90% of hospital patients touching one of their surgical and medical products

Healthcare
BUY
Becton Dickinson

Pays a good dividend, is held by institutions, great earnings and has global exposure.

Healthcare
TOP PICK
Becton Dickinson

Healthcare supplier in North America.
90% of products are disposable - creates recurring revenue.
Expecting double digit earnings growth.
Fantastic M&A growth with good management team.
Dividend growing at a regular pace.

Healthcare
WAIT
Becton Dickinson
The company supplies hospitals with medical supplies. 90% of their products are disposable. They have been hurt from COVID as operations have been delayed and it looks that may continue. In a normalized time, they are well situated for an aging population, which should translate into double-digits earnings growth going forward.
Healthcare
BUY
Becton Dickinson
Biggest manufacturer of syringes in the world. It is a large business with multiple moving parts so they have been range bound for the last little while. He likes their opportunities to generate cash flow and so it is a good name to hold.
Healthcare
HOLD
Becton Dickinson
Big medical supplies. They also have some proprietary parts of the business. He sold it about a month ago to buy one of today's top picks. You won't do too badly owning this going forward.
Healthcare
PAST TOP PICK
Becton Dickinson
(A Top Pick Apr 21/20, Down 4%) Hurt during Covid by surgeries not being performed. Should have a strong 2021.
Healthcare
HOLD
Becton Dickinson
He has no plans to sell it. They were very strong last year. It has been a little slow this year. You are not going to have explosive growth every single year. You might want to watch it and buy it if it dips coming out of the pandemic.
Healthcare
WAIT
Becton Dickinson
Syringes, IVs, disposable items. On his hot watch list. He's looking at hospital utilization rates. The market is waiting too. Once rates tick up, they'll be a direct beneficiary.
Healthcare
WATCH
Becton Dickinson
90% of the things they make are disposables. They make syringes among other things. The products are diversified and one does not dominate their revenues. There are many operations that should have happened but have not due to covid. Earnings will accelerate once covid has subsided and procedures restart.
Healthcare
WATCH
Becton Dickinson
90% of the things they make are disposables. They make syringes among other things. The products are diversified and one does not dominate their revenues. There are many operations that should have happened but have not due to covid. Earnings will accelerate once covid has subsided and procedures restart.
Healthcare
TOP PICK
Becton Dickinson

"Canadian Tire" of healthcare products for clinics and medical offices. Products are one-use only. Elective surgeries have been cancelled, so stock has not done much. Will shine in post-Covid era. Yield is 1.38%. (Analysts’ price target is $272.31)

Healthcare
BUY
Becton Dickinson

Healthcare gets knocked down before an election so there is a constant battle at this time of year and then it disappears after the election. This is a great company and continues to do well and you should own it or SYK-N, which he owns.

Healthcare
DON'T BUY
Becton Dickinson

BDX vs. BSX Owns Boston Scientific instead, with a strong history of execution. One-time events threw off that execution. Hospital procedures are coming back, which will benefit the entire industry. BSX is better known for innovation.

Healthcare
Showing 1 to 15 of 84 entries

Becton Dickinson(BDX-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 3

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 3

Stockchase rating for Becton Dickinson is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Becton Dickinson(BDX-N) Frequently Asked Questions

What is Becton Dickinson stock symbol?

Becton Dickinson is a American stock, trading under the symbol BDX-N on the New York Stock Exchange (BDX). It is usually referred to as NYSE:BDX or BDX-N

Is Becton Dickinson a buy or a sell?

In the last year, 3 stock analysts published opinions about BDX-N. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Becton Dickinson.

Is Becton Dickinson a good investment or a top pick?

Becton Dickinson was recommended as a Top Pick by on . Read the latest stock experts ratings for Becton Dickinson.

Why is Becton Dickinson stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Becton Dickinson worth watching?

3 stock analysts on Stockchase covered Becton Dickinson In the last year. It is a trending stock that is worth watching.

What is Becton Dickinson stock price?

On 2024-05-24, Becton Dickinson (BDX-N) stock closed at a price of $228.79.